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Abstract
Background: Brain synthesis of steroids including sex-steroids is attracting much attention. The endogenous synthesis of
corticosteroids in the hippocampus, however, has been doubted because of the inability to detect deoxycorticosterone
(DOC) synthase, cytochrome P450(c21).
Methodology/Principal Findings: The expression of P450(c21) was demonstrated using mRNA analysis and immmunogold
electron microscopic analysis in the adult male rat hippocampus. DOC production from progesterone (PROG) was
demonstrated by metabolism analysis of
3H-steroids. All the enzymes required for corticosteroid synthesis including
P450(c21), P450(2D4), P450(11b1) and 3b-hydroxysteroid dehydrogenase (3b-HSD) were localized in the hippocampal
principal neurons as shown via in situ hybridization and immunoelectron microscopic analysis. Accurate corticosteroid
concentrations in rat hippocampus were determined by liquid chromatography-tandem mass spectrometry. In
adrenalectomized rats, net hippocampus-synthesized corticosterone (CORT) and DOC were determined to 6.9 and
5.8 nM, respectively. Enhanced spinogenesis was observed in the hippocampus following application of low nanomolar
(10 nM) doses of CORT for 1 h.
Conclusions/Significance: These results imply the complete pathway of corticosteroid synthesis of ‘pregnenolone
RPROGRDOCRCORT’ in the hippocampal neurons. Both P450(c21) and P450(2D4) can catalyze conversion of PROG to
DOC. The low nanomolar level of CORT synthesized in hippocampal neurons may play a role in modulation of synaptic
plasticity, in contrast to the stress effects by micromolar CORT from adrenal glands.
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Introduction
The hippocampus is a target of corticosterone (CORT)
modulatory actions, with high levels of glucocorticoid receptor
(GR) and mineralocorticoid receptor (MR) expression [1,2].
Traditionally, CORT had been thought to be synthesized
exclusively in the adrenal cortex, reaching the brain via blood
circulation. De novo synthesis of CORT from PROG in the brain
has been doubted partly because brain CORT disappears after
adrenalectomy (ADX) in rats [3]. However, recent evidence shows
that the hippocampus expresses steroidogenic enzymes required
for corticosteroid synthesis, including cytochromes P450scc,
P450(11b1), P450(11b2), and 3b-hydroxysteroid dehydrogenase
(3b-HSD) [4-10]. Some of these enzymes are also necessary for
sex-steroid synthesis [11-14]. Yet, the complete corticosteroid
synthesis of ‘pregnenolone (PREG) R progesterone (PROG)R
deoxycorticosterone (DOC)RCORT or aldosterone (ALDO)’ in
the hippocampus has not been proven (see Fig. S1). Although
previous studies have shown parts of the corticosteroid synthesis
pathway in brain, including, PREGRPROG and DOCRCORT
and DOCRALDO[5,6,10], the conversion of PROGRDOC to
be demonstrated. Cytochrome P450(c21) (DOC synthase), a key
enzyme catalyzing the conversion of PROG to DOC, has not been
detected in the hippocampus, although mRNA expression has
been demonstrated in other brain regions including the hypothal-
amus, cortex, cerebellum and striatum [15,16].
In the current study, we demonstrated expression and activity of
P450(c21) and the complete metabolism of PROGRDOCR
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of cytochrome P450(2D4), another candidate for DOC synthase
[16,17], was also observed. Further, the net hippocampus-derived
CORT content was determined in ADX rats by mass-spectro-
metric analysis. We further investigated the effect of low dose
CORT on spinogenesis of hippocampal neurons in order to show
a possible role of hippocampus-derived CORT.
Results
Molecular biological analysis of corticosteroid
synthesizing enzymes
Cellular localization and expression of enzymes responsible
for CORT synthesis including P450(c21), P450(2D4),
P450(11b1), P450(11b2), and 11b-HSD (types 1 and 2) were
examined. Typical RT-PCR patterns of mRNA transcripts are
shown in Fig. 1. Because the expression level of P450(c21) is
extremely low in the hippocampus, we performed careful primer
design using minimization of Gibbs free energy (DG) upon
hybridization of primers with target sequences. We also choose
primers with DG for 5 bases in 39-side of the primer to be
larger than average DG for improved specificity, because
the specificity of primer-target recognition is mainly governed
by 39-side sequence of the primer. In the current study, DG
for 5 bases in 39-side of the P450(c21) primer was –6 kcal/mol,
which was larger than the average DG for the P450(c21) primer
(=–8 kcal/mol) (Fig. S2). As a result, we succeeded the detection
of P450(c21) mRNA.
Figure 1. RT-PCR analysis of enzymes required for corticosteroid synthesis in the adult (12-week old) male brain. (A) P450(c21), (B)
P450(2D4), (C) P450(11b1), (D) P450(11b2), (E) 11b-HSD (type 1), and (F) 11b-HSD (type 2). In panel A, from left to right, size marker (100 bp ladder),
Hi(+) hippocampus with template DNA, Hi(-) hippocampus without template DNA, Hy (+) hypothalamus with template DNA, and Hy (-) hypothalamus
without template DNA. The right most is the adrenal (Ad (+)) as the positive control. In P450(c21), the primer pairs (1) (top) identifies only an active
form of P450(c21). Both active form (281 bp) and inactive form (351 bp) are observed with primer pairs (2) (bottom). By comparison, almost all of
hippocampal P450(c21) is shown to be an active form.In each panel from left to right (B–F), size marker (M), cortex (CC), hippocampus (Hi), thalamus
(Th), hypothalamus (Hy), cerebellum (Ce), the sample without template DNA as negative control (Nc), and positive control. Liver (Li) for (B) and (E),
adrenal (Ad) for (C) and (D), and kidney (Ki) for (F) are used as positive control samples. For each enzyme, the RT-PCR products for mRNAs are
visualized with ethidium bromide staining (EB) on the top of each panel. Southern hybridization (SH) of cDNA is also shown on the middle of each
panel. As an internal control, the ethidium bromide staining of glyceraldehydes-3-phosphate dehydrogenase (GAPDH) is shown on the bottom of
each panel. Total RNAs used are 50 ng for each enzyme.
doi:10.1371/journal.pone.0021631.g001
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of adult male rats, was in the order of 1/20,000 of that in the
adrenal gland for P450(c21), almost same level of that in the liver
for P450(2D4), in the order of 1/10,000 of that in the adrenal
gland for P450(11b1), in the order of 1/5,000 of that in the
adrenal gland for P450(11b2), approximately 1/50 of that in the
liver for 11b-HSD (type 1), and approximately 1/500 of that in
the kidney for 11b-HSD (type 2) (Fig. 1). The mRNA expression
levels of P450(c21), P450(11b1), P450(11b2) and 11b-HSD (type
2) in the hippocampus were lower than those in the
hypothalamus. The expression level of P450(2D4) in the
hippocampus was almost equal of that in the hypothalamus.
The expression level of 11b-HSD (type 2) was higher than that in
the hypothalamus.
The cellular localization of P450(2D4), P450(11b1) and
P450(c21) was identified using in situ hybridization and immuno-
histochemical staining. Significant expressions of both P450(2D4)
and P450(11b1) were observed in pyramidal neurons (CA1, CA3)
and granule neurons (DG) and these enzymes were weakly
expressed in glial cells (Fig. 2 and S3). The weak expression of
P450(c21) was observed in pyramidal and granule neurons
(Fig. 2C). Because the expression level of mRNA for P450(c21)
was very low, the Tyramide signal amplification system was used
to obtain sufficient sensitivity.
Cellular and Subcellular localization of enzymes for
corticosteroid synthesis
Immunoelectron microscopic analysis using postembedding
immunogold was performed in order to determine the localization
of enzymes for corticosteroid synthesis (P450(c21), P450(2D4),
P450(11b1) and 3b-HSD) in the hippocampus. This method is
particularly useful to detect enzymes with extremely low
expression level such as P450(c21). All enzymes were mainly
localized in principal neurons including pyramidal neurons of CA1
and CA3 regions as well as granule neurons of the DG. Weak
expression was observed in some glial cells. P450(c21) and
P450(2D4) were localized not only in the endoplasmic reticulum
but also in both the axon terminals and dendritic spines of
principal neurons (Fig. 3A, 3B). P450(11b1) was localized in both
the mitochondria and synapses of principal neurons (Fig. 3C). We
also observed 3b-HSD in the synapses in addition to the
endoplasmic reticulum (Fig. 3D).
The subcellular localization of these enzymes was confirmed by
western blot with purified fractions of postsynaptic density,
endoplasmic reticulum and mitochondria (see Fig. S4 and
Text S1).
Mass-spectrometric analysis of corticosteroids in the
hippocampus
The concentration of CORT and DOC was determined in
steroid extracts from adult male rat hippocampus using a
chromatogram analysis of the fragmented ions (Fig. 4). After
selection of mother ions, fragmentation and detection were
performed via MS/MS procedures. Chromatographic profiles
for the fragmented ions of CORT (m/z=121) showed a clear
peak with the retention time of 3.19 min which was the same as
that of the fragmented ion of the standard CORT, indicating a
good specificity of the analysis (Fig. 4A). In the chromatographic
profiles of the fragmented ion of DOC (m/z=97), a single peak
was observed at 3.73 min (Fig. 4B).
In order to determine the net corticosteroids synthesis in the
hippocampus, we used ADX rats to eliminate adrenal-derived
steroids (CORT and DOC) via the blood circulation. Results
are summarized in Table 1. Two weeks after ADX, the
concentrations of CORT in the hippocampus and plasma were
2.4 ng/g wet weight (=6.9 nM) and 0.8 ng/ml (2.3 nM),
respectively. The DOC concentration was 1.9 ng/g wet weight
(5.9 nM) in the hippocampus, and 0.5 ng/ml (1.4 nM) in
plasma, respectively.
Even at 4 weeks after the ADX, the level of CORT did not
decrease further from the level at two weeks within experimental
error (62.1 nM, SEM). These results imply that the circulation-
derived CORT in the hippocampus was cleaned up already at two
weeks after ADX, therefore 6.9 nM is solely hippocampus-
synthesized CORT.
Validation of mass-spectrometric analysis
To confirm the assay accuracy, the hippocampal homoge-
nate spiked with known amounts of the steroids was prepared
and its concentration of steroid was determined (Table S1).
Satisfactory accuracy was obtained, supporting the accuracy of
determined hippocampal steroid content in Table 1. The limits
of quantifications (LOQs) were defined in Table S2 as the
lowest value with an acceptable accuracy (91.6–107.1 %) and
precision (i.e. RSD,11 %). The results of intra- and inter-assay
were shown in Table S2. The RSD for intra- and inter-assay
was less than 10.2 % and 10.9 %, respectively. These results
indicate that the present method is highly reproducible and
accurate.
In addition, we observed approximately 0.68 nM of 11-
deoxycortisol (roughly 1/10 of DOC) in the hippocampus.
Because P450(17a) is expressed in the hippocampus, DOCR11-
deoxycortisol R cortisol pathway may also work.
Hippocampal corticosteroid metabolism
Analysis of the pathway of corticosteroid metabolism is
necessary (Fig. S1), because mass-spectrometric determination
shows only the contents of individual steroids. The metabolism of
radioactive steroids in hippocampal slices was investigated using
normal phase HPLC. Hippocampal slices were incubated with
5610
6 cpm of
3H-labeled steroid substrate for 5 h. Typical results
of HPLC analysis are illustrated in Fig. 5. A significant production
of DOC from
3H-PROG was observed (Fig. 5A). The incubation
buffer contains 100 nM of finasteride, a specific inhibitor of 5a-
reductase, in order to reduce the conversion to 5a-reduced
metabolites such as allopregnanolone. Because of the strong
activity of 5a-reductase and 3a-HSD [18], some 5a-dihydro
PROG and TH-PROG (allopregnanolone) were produced even in
the presence of finasteride. In the absence of finasteride, the
production of DOC and CORT were very weak to observe. When
3H-DOC was used as a substrate, CORT from DOC was
produced (Fig. 5B). The conversion of CORT to other steroids
was very weak (Fig. 5C), indicating that CORT is stably present
once it produced.
Low dose effect of CORT on spinogenesis of
hippocampal neurons
To determine the potential physiological significance of
nanomolar concentrations of hippocampal CORT, we investigat-
ed CORT effects on dendritic spine density and morphology in
hippocampal ‘acute’ slices. It should be noted that CORT levels
were depleted in control ‘acute’ slices, containing only 1.9 nM
CORT following 2 h recovery incubation in ACSF. Treatment
with exogenous 10 nM CORT for 1 h significantly increased the
total spine density (1.18 spines/mm) compared with control slices
Synthesis of Corticosteroids in the Hippocampus
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hand, treatment with 100 nM CORT only slightly increased the
total spine density.
Morphological changes in spine head diameter induced by 1 h
CORT administration were also assessed. Spines were classified
into three categories based on head diameters: small-head spines
(0.2–0.4 mm): middle-head spines (0.4–0.5 mm): and large-head
spines (0.5–1.0 mm). Morphological categorization of spines into
three subclasses enabled complex responses in spine subpopula-
tions upon CORT application to be distinguished. Treatment with
Figure 2. In situ hybridization analysis of P450(2D4) (A), P450(11b1) (B) and P450(c21) (C). Reaction time for color development is 12 h.
(A1–2) Coronal sections of the whole hippocampus hybridized with antisense (A1) or sense (A2) probes for P450(2D4). (A3–4) The magnified images
of CA3 (A3) and DG (A4) in the hippocampus hybridized with antisense probes for P450(2D4). (B1–2) Coronal sections of the whole hippocampus
hybridized with antisense (B1) or sense (B2) probes for P450(11b1). (B3–4) The magnified images of CA1 (B3) and CA3 (B4) in the hippocampus
hybridized with antisense probes for P450(11b1). (C1–2) Coronal sections of the whole hippocampus hybridized with antisense (C1) or sense (C2)
probes for P450(c21). P450(2D4), P450(11b1) and P450(c21) are expressed in pyramidal neurons in CA1–CA3 region and granule cells in DG. Their
expression in glial cells is weak. Scale bar, 800 mm for (A1–2), (B1–2) and (C1–2); 120 mm for (A3), (A4), (B3) and (B4). Abbreviations: gcl, granule cell
layer; hl, hilus; pcl, pyramidal cell layer; so, stratum oriens; sr, stratum radiatum.
doi:10.1371/journal.pone.0021631.g002
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spines from 0.58 (control) to 0.81 spines/mm, while the density of
middle-head spines (approx. 0.28 spines/mm) and large-head
spines (approx. 0.12 spines/mm) was not significantly altered
(Fig. 6). Morphological changes induced by 100 nM CORT were
smaller than those induced by 10 nM CORT. The majority of
spines (.95%) had a distinct head and neck, therefore these
analysis cover major populations of spines.
Figure 3. Immunoelectron microscopic analysis of the distribution of the enzymes required for corticosteroid synthesis within the
axospinous synapses, in the stratum radiatum of the hippocampal CA1 region. (A) P450(c21), (B) P450(2D4), (C) P450(11b1), and (D) 3b -
HSD (type 1). P450(c21) and P450(2D4) are localized not only in the endoplasmic reticulum but also in both the axon terminals and dendritic spines of
principal neurons (A, B, arrowheads). P450(11b1) is localized in both the mitochondria and synapses of the principal neurons (C, arrowheads). post,
postsynaptic region (spine head). Scale bar, 200 nm, except for (B) left (100 nm).
doi:10.1371/journal.pone.0021631.g003
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In the current study, we clarified the complete pathway for
corticosteroid synthesis ‘PREGRPROGRDOCRCORT’ in
hippocampal neurons. We demonstrated for the first time the
expression, neuronal localization and activity of P450(c21) in the
hippocampus. In addition, the localization of P450(2D4), another
enzyme participating in DOC synthesis, was demonstrated.
Previous investigations of brain corticosteroids
PROGRDOC conversion and P450(c21) expression. To
date, direct evidence of DOC synthesis in the adult brain had not
been reported. No expression of P450(c21) in the rat/mouse
hippocampus has been reported, although a few studies have
reported weak expression of P450(c21) mRNA in some regions
of the rat brain such as hypothalamus, striatum, cerebellum
[15,16,19]. As an exception, weak expression of P450(c21)
mRNA was observed in the human hippocampus, with levels
1/20,000 of that of the adrenal gland [20]. Thus far, it has been
believed that P450(c21) is not physiologically active in the
hippocampus, and all CORT in the hippocampus is derived from
the adrenal glands via the blood circulation. Although P450(2D4)
has been known as the drug metabolizing P450, recently, it has
been demonstrated that P450(2D4) can also convert PROG to
DOC in hippocampus [16]. Therefore, both P450(c21) and
P450(2D4) could contribute to DOC production. We observed
the evidence of conversion of PROG to DOC, confirming de
novo synthesis of DOC.
DOCRCORTconversionand P450(11b1) expression. The
expression of P450(11b1) in the hippocampus has been described in
several studies and neuronal localization of P450(11b1) has been
demonstrated using immunohistochemistry [6,10,21]. We observed
the localization of P450(11b1) in cell bodies of pyramidal and
Figure 4. Mass-spectrometric analysis of hippocampal corticosteroids. LC-MS/MS ion chromatograms of CORT (A) and DOC (B). (A1), and
(B1) represent the chromatograms of the fragmented ions of each steroid from the hippocampus of ADX rats. Shaded portions indicate the intensity
of fragmented ions of CORT (m/z=121), and DOC (m/z=97), respectively. (A2) and (B2) represent the chromatograms of the fragmented ions of the
standard steroids. The vertical axis indicates the intensity of the fragmented ion. The horizontal axis indicates the retention time of the fragmented
ion, t=3.19 min for CORT (A1), and t=3.73 min for DOC (B1). The time of the injection to LC system is defined as t=0 min. Note that pre-purification
step using normal phase HPLC before injection to LC system is very important to achieve high precision and good reproducibility of LC-MS/MS
determination in order to avoid contamination of other steroids and fats. Steroids are further separated with reversed phase LC-column. In the
multiple reaction monitoring mode, the instrument monitored the m/z transition (Table S2).
doi:10.1371/journal.pone.0021631.g004
Table 1. Mass spectrometric analysis of the concentration of
steroids in the hippocampus and plasma of adult ADX male
rats.
Hippocampus Plasma
CORT (ng/g wet weight or mL) 2.460.6
a (n
b=11) 0.860.3 (n=11)
CORT (nM) 6.961.8 2.360.9
DOC (ng/g wet weight or mL) 1.960.5 (n=23) 0.560.1 (n=23)
DOC (nM) 5.861.4 1.460.3
aData are expressed as mean 6 SEM.
bNumber of animals (i.e. the number of hippocampi).
doi:10.1371/journal.pone.0021631.t001
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co-workers observe a weak CORT production from
3H-DOC,
roughly 0.4 pmol/mg/3 h in the hippocampus [6]. However, they
doubted de novo synthesis of CORT from PROG since CORT levels
inwholebrain werenigligible afteradrenalectomy(ADX) ofrats[3].
According to their report, CORT in the whole brain of five ADX
rats was below the detection limit, but four ADX rats had
measurable CORT in the brain (0.6 ng/g=1.8 nM). Therefore,
their results do not completely eliminate a possibility of the presence
of brain-synthesized CORT. It should be noted that the expression
level of P450(11b1) in the hippocampus does not change upon ADX
[21]. In the hippocampus of ADX rats we observed the direct
conversion of DOC to CORT (Fig. 5) as well as low, but
physiologically significant level of CORT. The expression of
P450(11b1) (both mRNA and protein) in neurons supports
endogenous synthesis. Interestingly, the expression level of
P450(11b1) is roughly 10-fold more in the cortex than in the
hippocampus.
Functional significance of hippocampus-synthesized
corticosteroids
The low nanomolar level of CORT, synthesized in the
hippocampal neurons, may play a essential role in enhancement
of synaptic plasticity, in contrast to the deleterious effects (e.g.,
neuronal cell death or shrinkage of dendrites) elicited by
micromolar plasma CORT secreted from the adrenal gland
under stressful conditions [22,23]. In the current study, low dose
CORT (10 nM) enhanced spinogenesis, particularly increasing the
density of small-head spines (Fig. 6). It has been previously
demonstrated that nanomolar doses of CORT (10 nM) drives the
Erk MAP kinase pathway, increasing both the expression and
phosphorylation of MAP kinase [24]. Taken together, hippocam-
pus-synthesized CORT (approx. 7 nM) might induce spinogenesis
via activation of the Erk MAP kinase pathway.
Earlier studies have also shown a range of beneficial effects of
nanomolar doses of CORT including strengthened signaling,
neuroprotection as well as a potential role in development [25,26].
Figure 5. Normal phase HPLC analysis of steroid metabolism in the hippocampal slices from adult male rat. (A) Typical HPLC profiles of
3H-PROG metabolites. DOC, allopregnanolone (Allo), dihydroprogesterone (dihydro PROG) are produced. U is unknown product. As previously
reported [42,43], 5a-DHPROG and allopregnanolone are observed. Several unknown peaks are also observed in the metabolism analysis. These
unknown products may be 7-hydroxylated steroids (such as 7a-OH PROG) or 20-hydroxylated steroids, because the expression of Cyp7b and 20a-
hydroxylase in the rodent hippocampus are reported [44,45]. (B) Typical HPLC profiles of
3H-DOC metabolites. (C) Typical HPLC profiles of
3H-CORT
metabolites. The incubation buffer contains 100 nM of finasteride, a specific inhibitor of 5a-reductase, in order to suppress the synthetic pathway of
5a-reduced metabolites such as allopregnanolone, because 5a-reductase is expressed in hippocampal principal neurons [18]. A portion of the
purified radioactive metabolites (total of 10
6 cpm) is analyzed using an HPLC system. Closed rectangle indicates the steroid used as substrate. Others
indicate products from substrate. The elution peak positions (arrows) are calibrated with standard
14C-steroids. The retention time of the (same)
standard
14C-steroid differed between each panel, due to the different elution experiments using the different silica gel columns. The vertical axis
indicates
3H radioactivity (cpm). Three to five independent experiments with different animals were performed for each of these analyses, showing
good reproducibility.
doi:10.1371/journal.pone.0021631.g005
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population spike, as did application of low concentration (5–
50 nM) of CORT to CORT-depleted slices [26]. Low doses of
CORT may also have neuroprotective effects. For example, low
dose CORT attenuates dexamethasone – induced apoptosis in
dentate gyrus via MR signaling pathway [27]. Nanomolar low
dose of CORT may also play a role in neuronal development, with
5–10 nM CORT found to enhance differentiation of neural stem
cells by inducing the expression of astrocyte marker GFAP (J
Kanno, K Igarashi, K Tanemura, H Asano, K Nakashima., 14
th
Int Cong of Endocrinol, Kyoto, 2010, P8-3-1).
Importantly, all the 7 nM of hippocampal CORT could
participateinmodulationofneuronalfunctionssuchasspinogenesis,
because corticosteroid binding globulin (CBG) and serum albumin
are not present in the hippocampus, therefore all the hippocampal
synthesized CORT should be biologically active. The persistence of
a significant concentration of corticosterone in the plasma (2 nM)
even after ADX may be derived from local synthesis in other
peripheral tissue such as adipocytes. Although we have a significant
concentration of CORT in the plasma, the majority (95–98%) of
plasma CORT may be biologically inactive in basal conditions, with
the majority of plasma CORT (90%) bound to CBG and a large
proportion of the remaining CORT bound to serum albumin [28].
Although basal plasma CORT levels range between 100 and
300 nM, biologically active free CORT comprises only 2–5% of the
total plasma CORT levels [29].
Moderate CORT level is kept by weak CORT production in
the hippocampus
A trace amount of endogenous DOC and CORT had been very
difficult to detect by
3H-steroid metabolism analysis, because many
different pathways exist other than PROGRDOCRCORT.
Therefore, we employed mass-spectrometric assay for detection
of a trace amount of these steroids in the hippocampus of ADX
rats. We determined the concentrations of DOC and CORT to be
5.8 nM and 6.9 nM, respectively. These values are comparable to
hippocampus-synthesized sex steroids such as estradiol (roughly
7 nM), testosterone (3 nM) and dihydrotestosterone (0.6 nM) [18].
Because the volume of hippocampus is very small (nearly 0.1 mL
for one whole hippocampus), the calculated concentrations were
Figure 6. Changes in the density and morphology of spines by low dose CORT in hippocampal slices. Spines were analyzed along the
secondary dendrites of pyramidal neurons in the stratum radiatum of CA1 neurons. Small-, middle-, and large-head spines are different in the density
of a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors [46], therefore these three types of spines may have different capacity of
synaptic transmission. The density of AMPA receptors in the spine is roughly proportional to its postsynaptic density (PSD) area size, whereas the
density of NMDA receptors is inversely proportional to the PSD area size. (A) Maximal intensity projections onto XY plane from z-series confocal
micrographs, showing spines along the secondary dendrites of hippocampal CA1 pyramidal neurons. Dendrites without CORT-treatments (Control)
and with 10 nM CORT treatment for 1 h (10 nM CORT). Bar, 4 mm. (B) Low dose CORT treatments on the total spine density. A 1 h treatment in ACSF
without drugs (0 nM), with 10 nM CORT (10 nM), with 100 nM CORT (100 nM). Vertical axis is the average number of spines per 1 mm of dendrite. (C)
Histogram of spine head diameters. After a 1 h treatment in ACSF without CORT (Control, open circle), with 10 nM CORT (10 nM, closed black circle),
and with 100 nM CORT (100 nM, open square). Vertical axis is the average number of spines per 1 mm of dendrite. (D) Density of three subtypes of
spines. From left to right, small-head spines (small), middle-head spines (middle), and large-head spines (large) are categolized. ACSF without CORT
(Control, open column), 10 nM CORT (10 nM, black column), and 100 nM CORT (100 nM, hatched column) are shown. In (B) and (D), results are
reported as mean 6 SEM. For each CORT treatment, we investigated, 3 rats, 6 slices, 12 neurons, 24 dendrites and roughly 1200 spines. In (B) and (D),
the significance of CORT was examined using the Tukey–Kramer post hoc multiple comparisons test when one way ANOVA tests yielded P,0.05.
*P,0.05, **P,0.01.
doi:10.1371/journal.pone.0021631.g006
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contents of DOC and CORT were only around 0.27 ng and
0.34 ng in one hippocampus with a weight of 0.14 g, respectively
(Table 1). Although steroid production capacity is strong in the
adrenal gland, circulation levels of steroids are diluted due to
approx. 20 mL of blood (200-fold of the hippocampal volume).
Though the hippocampal expression levels of enzymes (such as
P450(c21) and P450(11b1)) are roughly 1/20,000 and 1/10,000 of
those in the adrenal, they need to fill only small hippocampal
volume (1/200 of the blood volume).
It should be noted that the hippocampus-synthesized CORT is
stably present for even 5 h once produced (Fig. 5C), resulting in
keeping the CORT level sufficient for modulation of synaptic
plasticity. It may be due to roughly 1000-fold higher expression
level of 11b-HSD (type 1) in the hippocampus than that of 11b-
HSD (type 2) as judged from the cycle number of PCR (Figs. 1E
and 1F). Because 11b-HSD (type 1) converts 11-dehydrocorticos-
terone (inactive form) to CORT, hippocampal CORT is
prevented from inactivating once produced (Figs. 5C). On the
other hand, in peripheral tissues such as kidney, the expression
level of 11b-HSD (type2) is higher than that of 11b-HSD (type1).
Role of MR and GR
In ADX rats, the stress due to application of ether anesthetics
before decapitation did not increase hippocampal CORT level to
a high stress-level (e.g., 0.5–1 mM), therefore hippocampus-
synthesized CORT (roughly 7 nM) may not play a role in the
negative feedback by occupying many GR. Under basal
conditions, all MR may be occupied by ALDO or CORT.
Negative feedback would be induced by adrenal CORT. In
response to stress, 0.5–1 mM adrenal CORT, a part of which
penetrates into the hippocampus, could further occupy many
unoccupied GR in the hippocampus and could replace ALDO on
MR.
Conclusion
The hippocampus is equipped with not only sex-steroid
synthesis systems [11,13,14,30] but also corticosteroid synthesis
systems. Synaptic localization of important enzymes including
P450(c21), P450(2D4) and P450(11b1) suggests a potential
synaptocrine function of corticosteroids in hippocampal neurons.
These enzymes are also localized in the endoplasmic reticulum
(microsome) and mitochondria of hippocampal neurons, suggest-
ing potential synaptocrine function of corticosteroid synthesis in
hippocampal neurons. The current study opens new field of
investigations concerning possible physiological function of
hippocampus-synthesized nanomolar CORT, such as modulation
of synaptic plasticity.
Materials and Methods
Animals
Young adult male Wistar rats (12-week old) were purchased
from Saitama Experimental Animals Supply (Japan). All animals
were maintained under a 12 h light/12 dark exposure and free
access to food and water. Adrenalectomy (ADX) and sham
operations were performed two-weeks before the experiments.
The experimental procedure of this research was approved by the
Committee for Animal Research of the University of Tokyo (The
permission number is 19–10.).
Chemicals
Corticosterone (CORT), deoxycorticosterone (DOC) and pro-
gesterone (PROG) were purchased from Sigma (USA).
[2
13C3]PROG was from Hayashi Pure Chemical (Japan).
CORT-d8 and DOC-d8 were from CDN Isotope Inc. (Canada).
Finasteride was from Aska Pharma Medical (Japan). [
3H] or [
14C]
labeled steroids were purchased from Perkin Elmer (USA) and
their specific activities were 76.5 Ci/mmol ([1,2,6,7-
3H]-CORT)
and 102 Ci/mmol ([1,2,6,7-
3H]-PROG). [1,2-
3H]-DOC (50 Ci/
mmol) was purchased from Muromachi Yakuhin (Japan).
RT-PCR and Southern hybridization
The procedures were the same as described elsewhere [31].
Rats were deeply anesthetized with ethyl ether and decapitated.
The brains were then removed. Total RNAs including mRNA
were isolated from adult rat tissues such as the hippocampus,
hypothalamus, adrenal gland, kidney and liver, using a total RNA
Purification Kit (Nippongene, Japan). The purified RNAs were
quantified on the basis of the absorbance at 260/280 nm, and
treated with RNase-free DNase to eliminate the possibility of
genomic DNA contamination. The purified RNAs were reverse-
transcribed, using a M-MLV Reverse Transcriptase (Promega,
USA). The oligonucleotides for PCR amplification were designed
as illustrated in Table S3. The PCR protocols comprised
application of a 30 sec denaturation period at 95uC, a 2 sec
annealing period at individual temperature for each enzyme, and a
30 sec extension at 72uC, for individual number of cycles for each
enzyme (Table S3). For semiquantitative analysis, the RT-PCR
products were separated on 2% agarose gels, stained with
ethidium bromide, and analyzed with a fluorescence gel scanner
(Atto, Japan) and Image J software, in comparison with standard
curves obtained from PCR of diluted RT products (between 1/100
and 1/10,000 in dilution), from adrenal gland, kidney and liver.
To confirm the expression, Southern hybridization was
performed. The amplified RT-PCR products of steroidogenic
enzymes were directly cloned into TA-cloning vector (Promega,
USA), and sequenced. The resulting sequence was identical to the
reported cDNA sequences of these enzymes. These cloned
products were used as the template of DNA probes for Southern
hybridization. After transfer of the RT-PCR products from
agarose gels to nylon membrane (Hybond N+, Amersham,
USA), Southern hybridization was performed with
32P-labeled
cDNA probes for these enzymes. The Southern hybridization
signals were then measured using a BAS-1000 Image analyzer
(Fuji film, Japan).
In situ hybridization of hippocampal slices
Rats were deeply anesthetized with ethyl ether and decapitated.
The brains were removed and the hippocampus was dissected.
Preparation of adult hippocampal slices fixed with 4% parafor-
maldehyde, was performed essentially as described in elsewhere
[8,9,12]. The postfixed brain tissue was frozen-sliced coronally at
15 mm thickness with a cryostat (Leica, Germany) and slices were
immediately mounted on the slide glass at 218uC. Digoxigenin
(DIG)-labeled sense and antisense cRNA probes were in vitro
transcribed from PCR products of P450(11b1), P450(2D4) and
P450(c21) by using T7 or Sp6 promoters inherent in pGEM-T-
Easy vector. The hippocampal slices were treated with 10 mg/mL
of Proteinase K (Wako, Japan) for 10–20 minutes, and then
postfixed with fixative solution for 10 minutes. After acetylation
with acetic anhydride and dehydration, the mRNA in hippocam-
pal slices were hybridized with 0.5 mg/mL of DIG-labeled sense or
antisense cRNA probes. In order to digest and wash out the excess
cRNA probes, the slices were treated with RNase A (Wako, Japan)
and stringent washes after hybridization. For P450(11b1) and
P450(2D4), the slices were incubated with alkaline phosphatase-
conjugated anti-DIG antibody (Roche Diagnosis, USA) (1/1000)
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mRNAs were visualized by color development with 0.45 mg/mL
of nitro blue tetrazolium chloride (NBT) and 0.175 mg/mL of 5-
bromo-4-chloro-3-indoryl phosphate (BCIP) (Roche Diagnosis,
USA) for 12 h. For P450(c21), the sections were incubated with
horseradish peroxidase-conjugated anti-DIG antibody (Roche,
USA) (1/1000) for 30 min. To amplify signals of in situ
hybridization, the slides were incubated with dinitrophenyl labeled
amplification reagent using the TSA Plus DNP (AP) System
(Perkin Elmer, USA) and stained with NBT/BCIP for 12 h.
Post-embedding immunogold method for electron
microscopy
Rat hippocampal slices were prepared in essentially the same
manner as described elsewhere [32], except that slicing was
performed at 4uC using a vibratome instead of frozen slicing.
Brains from five animals were used and from each brain, a single
representative coronal section including the dorsal hippocampus
was processed for ultrathin sectioning. Freeze substitution and low-
temperature embedding of the specimens was performed as
described previously [32]. Briefly, slices were plunged into liquid
propane. The samples were immersed in uranyl acetate in
anhydrous methanol (290
uC), then infiltrated with Lowicryl
HM20 resin (Electron Microscopy Sciences, USA); polymerization
was performed with ultraviolet light. Ultrathin sections were cut
using a Reichert-Jung ultramicrotome. For immunolabeling,
sections were incubated with primary antibody for 3b-HSD(type1)
(1:500) [33], P450(c21) (1:2000) [34], P450(2D4) (1:500) [16] or
P450(11b) (1:1000) [35] in the above diluent overnight, then
incubated with secondary gold-tagged (10 nm) Fab fragment in
Tris-buffered saline (TBS). Sections were counter-stained with 1 %
uranyl acetate, and viewed on a JEOL 1200EX electron
microscope (Japan). Images were captured using the CCD camera
(Advanced Microscopy Techniques, USA). Controls omitting the
primary antibody were performed and no immunogold labeling
was observed. Controls of preadsorption incubating with purified
antigens were also performed and no immunogold labeling was
observed.
Mass-spectrometric assay of steroids
Detailed procedures are described elsewhere [18] (Text S1).
Step 1) Purification of steroids from hippocampi with
normal phase HPLC. The preparation of hippocampal
homogenates from slices and the extraction of steroids were
performed as described elsewhere [12].
3H-steroids (20,000 cpm
each) were added to homogenates as internal standards. The
steroid extracts were applied to a C18 Amprep solid phase column
(Amersham Biosciences, USA) to remove contaminating fats.
Then the steroids were separated into fractions of CORT, DOC
and PROG using a normal phase HPLC system (Jasco, Japan)
with an elution solvent of hexane: isopropylalcohol: acetic acid
=98:2:1. A silica gel column (Cosmosil 5SL, Nacalai Tesque,
Japan) was used. By monitoring
3H-steroids, the recovery of
CORT, DOC and PROG were 3561%, 3461%, and 4261%,
respectively, after extraction, C18 column treatment and normal
phase HPLC separation. Plasma was prepared by centrifugation
from trunk blood collected from decapitated rats [8].
Step 2) Determination of the concentration for CORT,
DOC and PROG using LC-MS/MS. At first, 100 pg of isotope
labeled steroids (
13C3-PROG, DOC-d8 and CORT-d8) were
added to steroid extracts prepared via Step 1). The LC-MS/MS
system, which consisted of a reverse phase LC (Agilent 1100,
Agilent Technologies, USA) coupled with an API 5000 triple-stage
quadrupole mass spectrometer (Applied Biosystems, USA), was
operated with electrospray ionization in the positive-ion mode.
The LC chromatographic separation was performed on a
Cadenza CD-C18 column (36150 mm, 3 mm, Imtakt Japan).
Detailed conditions for column purification were described in Text
S1 of Supporting Information. In the multiple reaction monitoring
mode, the instrument monitored the m/z transition, from 347 to
121 for CORT, from 331 to 97 for DOC, and from 315 to 109 for
PROG, respectively. Here, m and z represent the mass and charge
of a steroid derivative, respectively.
To examine specificity of LC-MS/MS analysis, samples were
spiked with steroid isotopes as internal standards. Though the m/z
transitions were different between CORT (from m/z=347 to 121)
and CORT-d8 (from m/z=355 to 125), their retention times were
the same, because the affinity of CORT for LC-column is same as
that for CORT-d8. In case of other steroids, there is also no
difference in the retention time between steroids and their
isotopes, though the m/z transitions were different. Isotope-
labeled steroid derivatives were also used for internal standards in
order to measure recovery of steroids. The recovery of CORT,
DOC and PROG were determined as 8968%, 7564% and
7166%, respectively, after purification and MS/MS detection.
Total recovery during all the steps was determined via
3H- and
isotope-labeled steroids in Step 1) and Step 2).
The limits of quantification for steroids were measured with
blank samples, prepared alongside hippocampal samples through
the whole extraction, fractionation and purification procedures.
The limits of quantification for CORT, DOC and PROG were
2 pg, 1 pg, and 2 pg per 0.1 g of hippocampal tissue or 1 mL of
plasma, respectively (Table S2).
From the calibration curve using standard steroids dissolved in
blank samples, the linearity was observed between 2 pg and
4000 pg for CORT, between 1 pg and 1000 pg for DOC, and
between 2 pg and 4000 pg for PROG, respectively (Fig S5).
Male Wistar rats were anesthetized with pentobarbital and
placed in a stereotaxic Because the LC-MS/MS enabled to
determine the exact level of CORT in the brain, we applied LC-
MS/MS to observe the circadian rhythm of CORT level in the
cerebrospinal fluid (CSF) in combination with the transverse
microdialysis [36,37]. Microdialysate was collected from the
cisterna magna in freely moving male Wistar rats every hour
(Fig. S6). Narishige apparatus (SR-5, Narishige, Japan) inserting a
transverse dialysis tube placed at the cisterna magna under the
guidance of a stainless steel wire attached in a horizontal position
to a stereotaxic holder [37]. The rats were allowed roughly 1 week
to recover from the surgery. Thereafter, the animals were moved
to an acrylic test box with the transverse probe being perfused with
a Ringer’s solution (138 mM NaCl, 2.4 mM KCl, 1.2 mM CaCl2,
[pH 7.0]) at 1 mL/min. Daily samples of CSF from the cisterna
magna were automatically collected every hour in a small vial.
The rats had free access to food placed on the floor of the test box
and to water given from the lid of the box.
Metabolism analysis of radioactive steroids using normal
phase HPLC
Procedures were essentially the same as previously described in
elsewhere [8,12]. The hippocampus from one rat was sliced into
400 mm thickness with a vibratome and incubated with
5610
6 cpm of [
3H]-steroids at 30uC for 5 h in 4 ml of
physiological saline containing 1.2 mM Mg
2+. The incubation
medium was gassed with 95% O2 and 5% CO2 during the
incubation in order to keep the activity of hippocampal neurons.
After termination of the reaction, the slices were homogenized. A
portion of the purified radioactive metabolites (total of 10
6 cpm)
Synthesis of Corticosteroids in the Hippocampus
PLoS ONE | www.plosone.org 10 July 2011 | Volume 6 | Issue 7 | e21631was analyzed using an HPLC system. Procedures used for the
analysis of steroid metabolites from hippocampal homogenates
with normal phase HPLC were the same as described in Step 1)o f
Mass-spectrometric assay. Fraction radioactivity was measured
using a liquid scintillation spectrometer LS6500 (Beckman, USA).
The rate of steroid production was normalized as products (cpm) /
g wet weight /5 h.
Imaging and analysis of dendritic spine density and
morphology
Slice preparation. Twelve weeks male rats were deeply
anesthetized with ethyl ether and decapitated. Immediately after
decapitation, the brain was removed from the skull and placed in
ice-cold oxygenated (95% O2,5 %C O 2) artificial cerebrospinal
fluid (ACSF) containing (in mM): 124 NaCl, 5 KCl, 1.25
NaH2PO4, 2 MgSO4, 2 CaCl2, 22 NaHCO3, and 10 D-glucose
(all from Wako); pH was set at 7.4. Hippocampal slices, 400 mm
thick, were prepared with a vibratome (Dosaka, Japan). These
slices were ‘freshly prepared’ slices without ACSF incubation.
Slices were then incubated in oxygenated ACSF for 2 h (slice
recovery processes) in order to obtain conventional ‘acute’ slices.
These acute slices were then incubated at room temperature with
CORT for 1 h. Then, slices were prefixed with 4%
paraformaldehyde at 4uC for 2–4 h.
Spine imaging and analysis with confocal microscopy was
performed as described previously [38–40].
Current injection of neurons by Lucifer Yellow. Neurons
within slices were visualized by an injection of Lucifer Yellow
under a Nikon E600FN microscope (Japan) equipped with a
C2400–79H infrared camera (Hamamatsu Photonics, Japan) and
with a 406water immersion lens (Nikon). Dye was injected with a
glass electrode filled with 5% Lucifer Yellow for 15 min, using
Axopatch 200B (Axon Instruments, USA). Approximately five
neurons within a 100–200 mm depth from the surface of a slice
were injected (Duan H et al., 2002). After labeling, slices were
fixed again with 4% paraformaldehyde at 4uC overnight.
Confocal laser microscopy and morphological
analysis. Imaging was performed from sequential z-series
scans with LSM5 PASCAL confocal microscope (Zeiss,
Germany). For analysis of spines, three-dimensional images were
constructed from approximately 40 sequential z-series sections of
neurons scanned every 0.45 mm with a 636water immersion lens,
NA 1.2 (Zeiss). The excitation and emission wavelengths were
488 nm and 515 nm, respectively. The applied zoom factor (3.0)
yielded 23 pixels per 1 mm. The z-axis resolution was
approximately 0.71 mm. The confocal lateral resolution was
approximately 0.26 mm. Our resolution limits were regarded as
sufficient to allow the determination of the density of thorns or
spines. Confocal images were then deconvoluted using
AUTODEBLUR software (AutoQuant, USA). The density of
spines as well as the head diameter was analyzed with Spiso-3D
(automated software calculating geometrical parameters of spines)
developed by Kawato’s group of Bioinformatics Project [41].
Spiso-3D has an equivalent capacity with Neurolucida
(MicroBrightField, USA), furthermore, Spiso-3D considerably
reduces human errors and experimenter labor. We analyzed the
secondary dendrites in the stratum radiatum, lying between 100
and 250 mm from the soma. The spine density was calculated from
the number of spines having a total length of 50–80 mm. Spine
shapes were classified into three categories as follows. (1) A small-
head spine whose head diameter is 0.2–0.4 mm. (2) A middle-head
spine whose head diameter is 0.4–0.5 mm. (3) A large-head spine
whose head diameter is 0.5–1.0 mm. These three categories were
useful to distinguish complex responses upon CORT application.
Because the majority of spines (.95%) had a distinct head and
neck, and stubby spines and filopodium did not contribute much
to overall changes, we analyzed spines having a distinct head.
While counting the spines in the reconstructed images, the position
and verification of spines was aided by rotation of three-
dimensional reconstructions and by observation of the images in
consecutive single planes.
Statistical analysis
Data were expressed as mean 6 SEM. For Table 1, an
unpaired, two-tailed t-test, under the assumption of unequal
variances, was utilized to test the significance of observed
differences between groups. Several numbers of independent
experiments from different animals were used to determine the
parameters of t-distribution for the test. For analysis of spinogen-
esis, we used Tukey–Kramer post hoc multiple comparisons test
when one way ANOVA tests yielded P,0.05.
Supporting Information
Text S1 Supporting information for materials and
methods, results, and discussions.
(DOC)
Figure S1 Pathways of corticosteroid synthesis in the
hippocampus. The abbreviated names of steroid (underline)
and enzyme (italic) involved in each reaction are indicated.
(TIF)
Figure S2 Gibbs free energy (DG) of P450c21 primer
pairs used in the current study. The vertical axis indicates
DG of the primer and template DNA. The dotted line indicates
the average of DG( DGav). We design these high sensitive primer
pairs which have higher DG for the 39-side primer than the 59-side
primer. The last five bases of the primers with the higher DG than
DGav avoid the non-specific amplification (closed bar).
(TIF)
Figure S3 Immunohistochemical staining for P450
(11b1) in the hippocampus. The coronal section of the whole
hippocampus is used. P450(11b1) is expressed in pyramidal
neurons in CA1-CA3 region and granule cells in DG. The
expression of P450(11b1) in glial cells is weak. Scale bar, 800 mm.
(TIF)
Figure S4 Western immunoblot analysis of P450c21 (A),
P450(2D4) (B), P450(11b1) (C), and 3b-HSD (type 1) (D) in
subcellular fractions of male rat hippocampus. From left
to right, postsynaptic membrane-rich fraction (Post), presynaptic
membrane-rich fraction (Pre), postsynaptic density fraction (PSD),
microsome (MS) and positive control. Adrenal gland (Ad) for (A)
and (C), Liver (Li) for (B), and ovary (Ov) for (D) were used as
positive control samples. The amount of protein applied to the gels
is 20 mg for each hippocampal fraction, 0.5 mg for Ad, and 1 mg
for ovary or liver.
(TIF)
Figure S5 Calibration curves for LC-MS/MS using
standard steroids dissolved in ethanol. Horizontal (x) axis
indicates the concentration of added standard steroid. Vertical (y)
axis indicates the relative intensity obtained from the chromato-
gram. (A) Calibration curve for CORT. Linearity is observed
between 2 pg/mL to 4000 pg/mL (in this figure only until
1000 pg/mL is shown). (B) Calibration curve for DOC. Linearity
is observed between 1 pg/mL to 1000 pg/mL.
(TIF)
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in the cerebrospinal fluid (CSF) from the cisterna magna
in freely moving rats. Rats with a microdialysis probe are
maintained in the 12 hr light/12 hr dark cycle. Samples are
collected every hour and 2 or 3 samples are combined and
averaged. Data are expressed as mean 6 SEM (n=3). Three
independent experiments with different animals were performed
for each of these analyses, showing good reproducibility.
(TIF)
Table S1 The accuracy of steroid determination for
hippocampal tissue spiked with exogenous steroids.
(DOC)
Table S2 The intra- and inter-assay of accuracy and
precision as well as the limit of quantification (LOQ) for
each steroid.
(DOC)
Table S3 The sequence of primer oligonucleotides for
PCR amplification.
(DOC)
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